NASDAQ · SNES

SenesTech, Inc.

Basic Materials · Chemicals - Specialty

$0.83▲ 1.10% ($0.01)today

As of 3:37 PM ET

52-week

$0.81$5.00

Market cap

$4.40M

P/E

-0.61

EPS (TTM)

-$1.32

Next earnings

Nov 9, 2026

No multiple

What the market price implies · Reverse DCF

Historical revenue grew by 40.13%/yr over the past 4 years.

Selected forecast · Base scenario

17.42%/yr · actual 10-year annualized revenue growth

Year 1 growth: 27.64%

Market-implied · Base operating assumptions + edited margins

Unavailable · flat 10-year annualized revenue growth

Reverse DCF solves revenue growth itself using Base operating assumptions and your edited margins. Changing forecast growth alone does not change the implied rate. This is a model-implied requirement, not an analyst forecast.

No supported revenue growth rate matches this price with these operating assumptions.

Valuation

Recommended · Revenue & margin DCF

Price used

$0.83

Estimated value / share

Unavailable

Base scenario

USD · TTM ending 2026-06-30

Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.

The discount rate uses the model's minimum bound. Limited beta or capital-structure data may affect this estimate.

Year 1 growth 27.64% · Ending margin 0% · Discount rate 5.45%

Assumption scenarios, not statistical confidence intervals.

Method, dates & sources

Estimated from future revenue, operating margins, and the investment needed to support them.

Price timestamp: Sep 17, 2026, 7:37 PM UTC
Financial statement period: TTM ending 2026-06-30
Data refreshed: Sep 17, 2026, 7:38 PM UTC · provider

Why this method?

There is not a stable run of positive FCFF to anchor a direct cash-flow CAGR, so the model should start from revenue and margin assumptions instead.

Is FCFF positive and has it been for 3+ consecutive years? Latest FCFF is not positive.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -81.96%Revenue (TTM): 13.43%FCF (TTM): -23.67%P/S: 14th pct

What changed

The stock fell 81.96% over the last year. Revenue grew 13.43% over the trailing twelve months. Operating margin moved from -290.54% to -303.66%. Free cash flow declined 23.67% over the trailing twelve months.

What the market seems to be pricing

The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.

What would invalidate this read

Operating margin currently stands at -303.66%. A decisive move in revenue — currently up 13.43% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

CEOMichael Edell

SectorBasic Materials

IndustryChemicals - Specialty

Employees24

IPO dateDec 7, 2016

https://www.senestech.com

Market multiples

Forward P/E—

EV/EBITDA-10.47

Enterprise value$65.21M

Stock splits

Jul 25, 2024↓ Reverse

Every 10 shares became 1

-90%

Nov 17, 2023↓ Reverse

Every 12 shares became 1

-92%

Nov 16, 2022↓ Reverse

Every 20 shares became 1

-95%

Feb 5, 2020↓ Reverse

Every 20 shares became 1

-95%

Profitability & growth

Revenue growth23.2%

Gross margin (FY2025)62.49%▲8.4ppvs FY2024

Operating margin (FY2025)-292.89%▲43.6ppvs FY2024

ROE-107.41%

Analyst consensus

RatingBuy

Target price—

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 9, 2026

Q4 FY26 · EPS est -$0.33 · Revenue est $797K

View

NASDAQ · SNES

SenesTech, Inc.

Basic Materials · Chemicals - Specialty

$0.83▲ 1.10% ($0.01)today

As of 3:37 PM ET

52-week

$0.81$5.00

Market cap

$4.40M

P/E

-0.61

EPS (TTM)

-$1.32

Next earnings

Nov 9, 2026

No multiple

What the market price implies · Reverse DCF

Historical revenue grew by 40.13%/yr over the past 4 years.

Selected forecast · Base scenario

17.42%/yr · actual 10-year annualized revenue growth

Year 1 growth: 27.64%

Market-implied · Base operating assumptions + edited margins

Unavailable · flat 10-year annualized revenue growth

No supported revenue growth rate matches this price with these operating assumptions.

Valuation

Recommended · Revenue & margin DCF

Price used

$0.83

Estimated value / share

Unavailable

Base scenario

USD · TTM ending 2026-06-30

Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.

The discount rate uses the model's minimum bound. Limited beta or capital-structure data may affect this estimate.

Year 1 growth 27.64% · Ending margin 0% · Discount rate 5.45%

Assumption scenarios, not statistical confidence intervals.

Method, dates & sources

Estimated from future revenue, operating margins, and the investment needed to support them.

Price timestamp: Sep 17, 2026, 7:37 PM UTC
Financial statement period: TTM ending 2026-06-30
Data refreshed: Sep 17, 2026, 7:38 PM UTC · provider

Why this method?

There is not a stable run of positive FCFF to anchor a direct cash-flow CAGR, so the model should start from revenue and margin assumptions instead.

Is FCFF positive and has it been for 3+ consecutive years? Latest FCFF is not positive.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -81.96%Revenue (TTM): 13.43%FCF (TTM): -23.67%P/S: 14th pct

What changed

What the market seems to be pricing

What would invalidate this read

Operating margin currently stands at -303.66%. A decisive move in revenue — currently up 13.43% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

CEOMichael Edell

SectorBasic Materials

IndustryChemicals - Specialty

Employees24

IPO dateDec 7, 2016

https://www.senestech.com

Market multiples

Forward P/E—

EV/EBITDA-10.47

Enterprise value$65.21M

Stock splits

Jul 25, 2024↓ Reverse

Every 10 shares became 1

-90%

Nov 17, 2023↓ Reverse

Every 12 shares became 1

-92%

Nov 16, 2022↓ Reverse

Every 20 shares became 1

-95%

Feb 5, 2020↓ Reverse

Every 20 shares became 1

-95%

Profitability & growth

Revenue growth23.2%

Gross margin (FY2025)62.49%▲8.4ppvs FY2024

Operating margin (FY2025)-292.89%▲43.6ppvs FY2024

ROE-107.41%

Analyst consensus

RatingBuy

Target price—

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 9, 2026

Q4 FY26 · EPS est -$0.33 · Revenue est $797K

View